当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 现金流量表

海正药业

(600267)

  

流通市值:133.78亿  总市值:133.78亿
流通股本:11.99亿   总股本:11.99亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,824,279,976.5511,160,388,744.468,563,322,286.315,791,576,436.27
  收到的税费返还3,576,747.6112,275,558.113,156,921.236,656,615.08
  收到其他与经营活动有关的现金59,956,036.49356,429,834.69389,705,714.36310,601,342.47
  经营活动现金流入小计2,887,812,760.6511,529,094,137.258,966,184,921.96,108,834,393.82
  购买商品、接受劳务支付的现金973,099,597.525,131,740,533.083,882,573,352.922,541,822,928.51
  支付给职工以及为职工支付的现金659,366,208.671,785,937,977.631,369,853,580.84960,409,709.4
  支付的各项税费286,099,226.5817,826,210.59602,712,320.28431,873,697
  支付其他与经营活动有关的现金518,419,818.351,761,913,400.531,466,382,116.79963,693,649.24
  经营活动现金流出小计2,436,984,851.049,497,418,121.837,321,521,370.834,897,799,984.15
  经营活动产生的现金流量净额450,827,909.612,031,676,015.421,644,663,551.071,211,034,409.67
二、投资活动产生的现金流量:
  收回投资收到的现金4,250,000---
  取得投资收益收到的现金-11,544,40016,344,491.3311,544,400
  处置固定资产、无形资产和其他长期资产收回的现金净额313,575.4214,677,947.533,913,015.13,410,361.32
  处置子公司及其他营业单位收到的现金净额465,311,216.41---
  收到的其他与投资活动有关的现金1,054,00560,017,10055,136,592.373,416,283.82
  投资活动现金流入小计470,928,796.8386,239,447.5375,394,098.818,371,045.14
  购建固定资产、无形资产和其他长期资产支付的现金127,735,066.71376,395,257.64215,322,290.41112,627,963.27
  投资支付的现金-78,284,936.6555,784,936.6530,784,936.65
  支付其他与投资活动有关的现金138,367,752.87660,0002,960,022.352,229,894.35
  投资活动现金流出小计266,102,819.58455,340,194.29274,067,249.41145,642,794.27
  投资活动产生的现金流量净额204,825,977.25-369,100,746.76-198,673,150.61-127,271,749.13
三、筹资活动产生的现金流量:
  取得借款收到的现金741,000,0002,357,854,777.041,431,330,849.251,195,029,200.48
  筹资活动现金流入小计741,000,0002,357,854,777.041,431,330,849.251,195,029,200.48
  偿还债务支付的现金767,178,7303,558,356,912.962,292,217,7961,531,217,796
  分配股利、利润或偿付利息支付的现金14,605,856.13343,424,482.78323,720,682.87299,991,018.87
  支付其他与筹资活动有关的现金35,892,040.1989,461,043.4259,018,938.5956,613,187.87
  筹资活动现金流出小计817,676,626.323,991,242,439.162,674,957,417.461,887,822,002.74
  筹资活动产生的现金流量净额-76,676,626.32-1,633,387,662.12-1,243,626,568.21-692,792,802.26
四、汇率变动对现金及现金等价物的影响-1,508,819.97-887,015.79231,228.83677,653.75
五、现金及现金等价物净增加额577,468,440.5728,300,590.75202,595,061.08391,647,512.03
  加:期初现金及现金等价物余额1,218,184,997.461,189,884,406.711,189,884,406.71,189,884,406.7
  期末现金及现金等价物余额1,795,653,438.031,218,184,997.461,392,479,467.781,581,531,918.73
补充资料:
  净利润-547,485,702.43-304,913,629.54
  资产减值准备-213,171,765.88-142,462,387.53
  固定资产和投资性房地产折旧-839,605,626.49-426,759,845.36
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-839,605,626.49-426,759,845.36
  无形资产摊销-119,836,009.25-57,508,038.08
  长期待摊费用摊销-2,950,260.29-1,540,903.45
  处置固定资产、无形资产和其他长期资产的损失--5,234,365.98--305,012.36
  固定资产报废损失-2,619,979.32-325,243.78
  公允价值变动损失-34,782,686.47-35,878,704.73
  财务费用-102,918,776.73-53,587,757.24
  投资损失-34,724,323.36-29,880,317.54
  递延所得税-28,719,719.04-28,933,138.19
  其中:递延所得税资产减少-28,898,364.59-28,950,839.67
    递延所得税负债增加--178,645.55--17,701.48
  存货的减少-66,089,346.39-128,612,507.42
  经营性应收项目的减少-33,090,521.08-108,333,202.62
  经营性应付项目的增加--59,352,548.42--118,131,538.34
  其他-512,982.57-323,184.74
  现金的期末余额-1,218,184,997.46-1,581,531,918.73
  减:现金的期初余额-1,189,884,406.71-1,189,884,406.7
  现金及现金等价物的净增加额-28,300,590.75-391,647,512.03
公告日期2026-04-282026-04-082025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑